https://www.selleckchem.com/pr....oducts/Gefitinib.htm
90μmol/L), albumin (lower reference limit 41g/L, vs. 35g/L), AST (URL 50 U/L vs. 35 U/L), ALP (URL 118 U/L vs. 98 U/L) and oestradiol (URL 934 pmol/L vs. 213 pmol/L) were noted, respectively. Significantly higher LDL-C was observed for TM on hormone treatment, compared to baseline (2.9mmol/L vs. 2.2mmol/L, 0.01). Biochemical results for TM and TF receiving hormone therapy can be evaluated against our transgender-specific reference intervals for some analytes, while others can be compared to their identified gender reference interv
Curtir
Comentario
Compartilhar
